CDNS Form 4: Paul Cunningham Disposes 1,000 Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
Cadence Design Systems insider sale disclosed. Paul Cunningham, Senior Vice President, sold 1,000 shares of Cadence common stock on 09/02/2025 at a reported price of $343.95 per share under a Rule 10b5-1 trading plan adopted on 03/14/2025. After the transaction he is reported to beneficially own 102,499 shares. The Form 4 was submitted with a signature by an attorney-in-fact on 09/04/2025. The filing discloses a routine, prearranged sale by an officer rather than an open-market ad hoc trade.
Positive
- Transaction executed under a Rule 10b5-1 trading plan, which supports compliance and reduces signaling risk
- Full disclosure provided including transaction date, price, quantity, and post-transaction beneficial ownership
Negative
- None.
Insights
TL;DR: Officer sold a small block under a 10b5-1 plan; disclosure is routine and likely not material to fundamentals.
The Form 4 shows a single sale of 1,000 shares by Senior Vice President Paul Cunningham at $343.95 executed pursuant to a Rule 10b5-1 trading plan adopted 03/14/2025. The filing reports 102,499 shares beneficially owned after the sale. This is a standard insider disclosure that provides transparency about officer liquidity but does not include any company operational or financial updates. Investors should view this as routine insider selling under a prearranged plan rather than an event signaling a change in company performance.
TL;DR: Use of a 10b5-1 plan indicates preplanned, compliant execution; filing meets Section 16 disclosure requirements.
The report explicitly states the transaction was effected pursuant to a Rule 10b5-1 trading plan, which provides an affirmative defense to insider trading allegations when properly adopted. The Form 4 contains the required details: transaction date, quantity sold, sale price, and post-transaction beneficial ownership, and it is executed by an attorney-in-fact. From a governance perspective, the filing reflects appropriate disclosure practices for an officer sale; it contains no indications of policy violations or governance concerns.